Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Regenxbio (RGNX) Leases (2019 - 2025)

Historic Leases for Regenxbio (RGNX) over the last 7 years, with Q3 2025 value amounting to $48.8 million.

  • Regenxbio's Leases fell 1170.67% to $48.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $48.8 million, marking a year-over-year decrease of 1170.67%. This contributed to the annual value of $53.7 million for FY2024, which is 1119.41% down from last year.
  • Regenxbio's Leases amounted to $48.8 million in Q3 2025, which was down 1170.67% from $50.5 million recorded in Q2 2025.
  • Over the past 5 years, Regenxbio's Leases peaked at $65.1 million during Q4 2022, and registered a low of $48.8 million during Q3 2025.
  • For the 5-year period, Regenxbio's Leases averaged around $58.7 million, with its median value being $60.2 million (2022).
  • As far as peak fluctuations go, Regenxbio's Leases surged by 62125.07% in 2021, and later plummeted by 1170.67% in 2025.
  • Regenxbio's Leases (Quarter) stood at $60.9 million in 2021, then rose by 6.92% to $65.1 million in 2022, then decreased by 7.11% to $60.5 million in 2023, then decreased by 11.19% to $53.7 million in 2024, then dropped by 9.11% to $48.8 million in 2025.
  • Its last three reported values are $48.8 million in Q3 2025, $50.5 million for Q2 2025, and $52.1 million during Q1 2025.